Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wang, Chao
  • Rasmussen, Henrik
  • Perrow, Wendy
  • Kelly, Ciaran P
  • Leffler, Daniel
  • Green, Peter
  • Fedorak, Richard N
  • DiMarino, Anthony J
  • Bercik, Premysl
  • Murray, Joseph A
  • Bachir, Natalie M

publication date

  • May 1, 2014